Evicenter
MarkdownMedical informationP&T meetings
Lanifibranor (IVA337)

Metabolic dysfunction-associated steatohepatitis with F2 to F3 fibrosis

Manufacturer
Inventiva
Last updated
220 sources

Product information and disease descriptionProduct descriptionProduct information

Special populations

18 evidence topics · 9 sources

Renal impairment: dedicated pharmacokinetic study

No evidence found.

Hepatic impairment: dedicated pharmacokinetic study

No evidence found.

Pediatric population: pediatric studies

No evidence found.